Clinical Trial Update: Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs [Phase 1]

View source ↗

Summary

This Phase 1 drug interaction study completed evaluating how darunavir/ritonavir and lopinavir/ritonavir affect the pharmacokinetics of GSK2248761 and CYP450 pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED